Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Zaccardelli

David Zaccardelli is recorded as Board Member and Chairman at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed January 7, 2026 that David Zaccardelli was appointed Chairperson of the Board, effective January 5, 2026. SAB Biotherapeutics, Inc. reported in an 8-K filed January 7, 2026 that David Zaccardelli was appointed Class II director, effective January 5, 2026.

“Dr. Zaccardelli will act as Chairperson of the Board.”
SAB Biotherapeutics, Inc. Form 8-K, filed January 7, 2026 · Read the filing
“On January 5, 2026, the Board of Directors (the "Board") of SAB Biotherapeutics, Inc., a Delaware corporation (the "Company"), following the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed, David Zaccardelli, Pharm.D, and Rita Jain, M.D. each to serve as a Class II director of the Company, effective January 5, 2026, and to serve until the Company's 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified.”
SAB Biotherapeutics, Inc. Form 8-K, filed January 7, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at SAB Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.